Owner BioCryst Pharmaceuticals, Inc.

Inventors Babu, Yarlagadda S.; Kamath, Vivekanand P.; Morris, Jr. Philip E.

Agent EF WELLINGTON & CO

Pub. Number AU-A-2005269541

PCT Pub. Number WO2006/014913

Priority 60/619,126 15.10.04 US; 60/591,442 27.07.04 US

Filing date 26 July 2005

Wipo publication date 9 February 2006

C07D 487/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

A61K 31/519 (2006.01) - ortho- or peri-condensed with heterocyclic rings

A61K 31/4015 (2006.01) - having oxo groups directly attached to the heterocyclic ring, e.g. piracetam, ethosuximide

A61K 31/4025 (2006.01) - not condensed and containing further heterocyclic rings, e.g. cromakalim

A61K 31/506 (2006.01) - not condensed and containing further heterocyclic rings

C07D 207/12 (2006.01) Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom

C07D 207/22 (2006.01) Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom

C07D 239/32 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

C07D 239/42 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

C07D 239/47 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

C07D 239/48 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

C07D 239/50 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings